Ultrasound molecular imaging of arterial thrombi with novel microbubbles modified by cyclic RGD in vitro and in vivo

Thrombosis and Haemostasis

Volumn 107, Issue 1, 2012, Pages 172-183

  Hu, Guangquan ^a   Liu, Cheng ^a,b   Liao, Yulin ^a   Yang, Li ^a   Huang, Ruizhu ^a   Wu, Juefei ^a   Xie, Jiajia ^a   Bundhoo, Kaviraj ^a   Liu, Ying ^a   Bin, Jianping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Arterial thrombus; Cyclic RGD; Microbubbles; Ultrasound molecular imaging

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRINOGEN RECEPTOR;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA THROMBOSIS; ARTERY THROMBOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ENHANCEMENT; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; THROMBOCYTE RICH THROMBUS; ULTRASOUND; ULTRASOUND MOLECULAR IMAGING;

ANIMALS; ARTERIES; BLOOD PLATELETS; HUMANS; MICROBUBBLES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGOPEPTIDES; PEPTIDES; RATS; RATS, WISTAR; SHEAR STRENGTH; STRESS, MECHANICAL; THROMBOSIS; TIME FACTORS; ULTRASONICS;

EID: 84855311082     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-11-0701     Document Type: Article

References (45)

1. Ebbesen LS. Hyperhomocysteinemia, thrombosis and vascular biology. Cellular and molecular biology (Noisy-le-Grand, France) 2004; 50: 917-930.
2. Naemura A, Ohira H, Ikeda M, et al. An experimentally antithrombotic strawberry variety is also effective in humans. Pathophysiol Haemost Thromb 2006; 35: 398-404.
3. Shantaram V. Pathogenesis of atherosclerosis in diabetes and hypertension. Clin Exp Hypertens 1999; 21: 69-77.
4. Corti R, Osende JI, Fayad ZA, et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol 2002; 39: 1366-1373.
5. Saraste A, Nekolla SG, Schwaiger M. Cardiovascular molecular imaging: an overview. Cardiovasc Res 2009; 83: 643-652.
6. Hwang M, Lyshchik A, Fleischer AC. Molecular sonography with targeted microbubbles: current investigations and potential applications. Ultrasound Quart 2010; 26: 75-82.
7. Alonso A, Della Martina A, Stroick M, et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007; 38: 1508-1514.
8. Lowe GD. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb 2003; 33: 455-457.
9. Stoll P, Bassler N, Hagemeyer CE, et al. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation. Arterioscl Thromb Vasc Biol 2007; 27: 1206-1212.
10. Plow EF, Cierniewski CS, Xiao Z, et al. AlphaIIbbeta3 and its antagonism at the new millennium. Thromb Haemost 2001; 86: 34-40.
11. Haas TA. Allosteric regulation of alpha(IIb)beta(3) by beta(3) 95-105. Thromb Haemost 2008; 99: 701-710.
12. Unger EC, McCreery TP, Sweitzer RH, et al. In vitro studies of a new thrombusspecific ultrasound contrast agent. Am J Cardiol 1998; 81: 58G-61G.
13. Takeuchi M, Ogunyankin K, Pandian NG, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): In vivo experimental echocardiographic studies. J Am Soc Echocardiogr 1999; 12: 1015-1021.
14. Schumann PA, Christiansen JP, Quigley RM, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002; 37: 587-593.
15. Imura Y, Stassen JM, Vreys I, et al. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model. Thromb Haemost 1992; 68: 336-340.
16. Bogdanowich-Knipp SJ, Chakrabarti S, Williams TD, et al. Solution stability of linear vs. cyclic RGD peptides. J Pept Res 1999; 53: 530-541.
17. Bogdanowich-Knipp SJ, Jois DS, Siahaan TJ. The effect of conformation on the solution stability of linear vs. cyclic RGD peptides. J Pept Res 1999; 53: 523-529.
18. Wang Y, Goh SY, Kuczera K. Molecular dynamics study of disulfide bond influence on properties of an RGD peptide. J Pept Res 1999; 53: 188-200.
19. Kato M, Mrksich M. Using model substrates to study the dependence of focal adhesion formation on the affinity of integrin-ligand complexes. Biochemistry 2004; 43: 2699-2707.
20. Dijkgraaf I, Boerman OC, Oyen WJ, et al. Development and application of peptide-based radiopharmaceuticals. Anti-cancer Agents Med Chem 2007; 7: 543-551.
21. Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharmaceutics 2006; 3: 472-487.
22. Liu S. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconj Chem 2009; 20: 2199-2213.
23. Sinha D, Shukla G, Chuttani K, et al. Synthesis and biological evaluation of (99m)Tc-DTPA-bis(His) as a potential probe for tumor imaging with SPECT. Cancer Biother Radiopharm 2009; 24: 615-620.
24. Basly B, Felder-Flesch D, Perriat P, et al. Dendronized iron oxide nanoparticles as contrast agents for MRI. Chemical Comm 2010; 46: 985-987.
25. Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconj Chem 2005; 16: 9-17.
26. Anderson CR, Rychak JJ, Backer M, et al. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol 2010; 45: 579-585.
27. Xie H, Diagaradjane P, Deorukhkar AA, et al. Integrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int J Nanomed 2011; 6: 259-269.
28. Takalkar AM, Klibanov AL, Rychak JJ, et al. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 2004; 96: 473-482.
29. Klibanov AL, Rychak JJ, Yang WC, et al. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imag 2006; 1: 259-266.
30. Higuchi T, Bengel FM, Seidl S, et al. Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res 2008; 78: 395-403.
31. Martin MJ, Chung EM, Goodall AH, et al. Enhanced detection of thromboemboli with the use of targeted microbubbles. Stroke 2007; 38: 2726-2732.
32. Haubner R, Bruchertseifer F, Bock M, et al. Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmed 2004; 43: 26-32.
33. Dunehoo AL, Anderson M, Majumdar S, et al. Cell adhesion molecules for targeted drug delivery. J Pharmaceut Sci 2006; 95: 1856-1872.
34. Haubner R, Wester HJ. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr Pharmaceut Design 2004; 10: 1439-1455.
35. Haubner R. Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? Eur J Nuclear Med Mol Imag 2006; 33 (Suppl 1): 54-63.
36. Seo JW, Mahakian LM, Kheirolomoom A, et al. Liposomal Cu-64 Labeling Method Using Bifunctional Chelators: Poly(ethylene glycol) Spacer and Chelator Effects. Bioconjug Chem 2010; 21: 1206-1215.
37. Feldwisch J, Tolmachev V, Lendel C, et al. Design of an optimized scaffold for affibody molecules. J Mol Biol 2010; 398: 232-247.
38. Cherkaoui S, Bettinger T, Hauwel M, et al. Tracking of antibody reduction fragments by capillary gel electrophoresis during the coupling to microparticles surface. J Pharma Biomed Anal 2010; 53: 172-178.
39. Choi H, Aboulfatova K, Pownall HJ, et al. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem 2007; 282: 35604-35611.
40. Li Y, Choi H, Zhou Z, et al. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost 2008; 6: 1135-1143.
41. Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol 2007; 18: 11-16.
42. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996; 94: 3334-3340.
43. Gupta AS, Huang G, Lestini BJ, et al. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb Haemost 2005; 93: 106-114.
44. Chen H, Mo W, Su H, et al. Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities. BMC molecular Biol 2007; 8: 88.
45. Kochanowski R, Kotlowski R, Szweda P. Expression and intein-mediated purification of novel staphylokinase SakSTAR with reduced immunogenicity and antiplatelet and antithrombin activation. Appl Biochem Biotechnol 2007; 141: 321-333.